Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Harvard Business School
Queensland Health
Julphar
Chubb
Medtronic

Generated: May 22, 2019

DrugPatentWatch Database Preview

Drug Price Trends for OLANZAPINE

« Back to Dashboard

Drug Price Trends for OLANZAPINE

Average Pharmacy Cost for OLANZAPINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Glossary
Drug Name NDC Price/Unit ($) Unit Date
OLANZAPINE 20 MG TABLET 69543-0385-90 0.22906 EACH 2019-02-20
OLANZAPINE 20 MG TABLET 69543-0385-30 0.22906 EACH 2019-02-20
OLANZAPINE 15 MG TABLET 69543-0384-90 0.18151 EACH 2019-02-20
OLANZAPINE 15 MG TABLET 69543-0384-30 0.18151 EACH 2019-02-20
Drug Name NDC Price/Unit ($) Unit Date

Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for OLANZAPINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
ZYPREXA RELPREVV INTRAMUSCULAR 405MG F/INJ Eli Lilly & Company 00002-7637-11 1 851.28 851.28000 EACH 2018-08-01 - 2023-07-31 Big4
ZYPREXA 7.5MG TAB Eli Lilly & Company 00002-4116-30 30 325.81 2019-01-01 - 2023-07-31 Big4
ZYPREXA ZYDIS 5MG TAB Eli Lilly & Company 00002-4453-85 30 296.80 9.89333 EACH 2018-08-01 - 2023-07-31 Big4
ZYPREXA RELPREVV INTRAMUSCULAR 405MG F/INJ Eli Lilly & Company 00002-7637-11 1 851.28 2019-01-01 - 2023-07-31 Big4
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Queensland Health
Moodys
Mallinckrodt
Cipla
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
 NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: